Alteration of ribosome function upon 5-fluorouracil treatment favors cancer cell drug-tolerance - Archive ouverte HAL
Article Dans Une Revue Nature Communications Année : 2022

Alteration of ribosome function upon 5-fluorouracil treatment favors cancer cell drug-tolerance

Alexandre David
Julie Pannequin

Résumé

Mechanisms of drug-tolerance remain poorly understood and have been linked to genomic but also to non-genomic processes. 5-fluorouracil (5-FU), the most widely used chemotherapy in oncology is associated with resistance. While prescribed as an inhibitor of DNA replication, 5-FU alters all RNA pathways. Here, we show that 5-FU treatment leads to the production of fluorinated ribosomes exhibiting altered translational activities. 5-FU is incorporated into ribosomal RNAs of mature ribosomes in cancer cell lines, colorectal xenografts, and human tumors. Fluorinated ribosomes appear to be functional, yet, they display a selective translational activity towards mRNAs depending on the nature of their 5'-untranslated region. As a result, we find that sustained translation of IGF-1R mRNA, which encodes one of the most potent cell survival effectors, promotes the survival of 5-FU-treated colorectal cancer cells. Altogether, our results demonstrate that "man-made" fluorinated ribosomes favor the drug-tolerant cellular phenotype by promoting translation of survival genes.
Fichier principal
Vignette du fichier
s41467-021-27847-8.pdf (2.7 Mo) Télécharger le fichier
5fu_highlight.pdf (244.99 Ko) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03523177 , version 1 (03-02-2022)

Licence

Identifiants

Citer

Gabriel Therizols, Zeina Bash-Imam, Baptiste Panthu, Christelle Machon, Anne Vincent, et al.. Alteration of ribosome function upon 5-fluorouracil treatment favors cancer cell drug-tolerance. Nature Communications, 2022, 13 (1), pp.173-187. ⟨10.1038/s41467-021-27847-8⟩. ⟨hal-03523177⟩

Relations

319 Consultations
151 Téléchargements

Altmetric

Partager

More